60 Degrees Pharmaceuticals, Inc. (SXTP)
0.9495
-0.07
(-6.91%)
USD |
NASDAQ |
Sep 02, 16:00
0.9651
+0.02
(+1.64%)
After-Hours: 20:00
60 Degrees Pharmaceuticals Research and Development Expense (Annual) : 2.106M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 2.106M |
| December 31, 2024 | 4.986M |
| December 31, 2023 | 0.6918M |
| Date | Value |
|---|---|
| December 31, 2022 | 0.5256M |
| December 31, 2021 | 5.511M |
| December 31, 2020 | 0.8067M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Harrow, Inc. | 12.85M |
| ANI Pharmaceuticals, Inc. | 51.66M |
| Corcept Therapeutics, Inc. | 254.91M |
| Veru, Inc. | 15.59M |
| Johnson & Johnson | 14.83B |